Skip to main content
. 2013 May 3;9:94. doi: 10.1186/1746-6148-9-94

Figure 1.

Figure 1

B-cell lymphoma FNAs. (a) low number of positive immunoassayed lymphoid tumour cells for MMP-2 antibody (arrow); (b) numerous positive immunoassayed lymphoid tumour cells for MMP-9 antibody (arrow); (c) plasma cells and low percentage of immunoassayed lymphoid tumour cells for VEGF-A antibody (arrows). Immunocytochemistry, 400×.